<DOC>
	<DOCNO>NCT02799446</DOCNO>
	<brief_summary>The purpose study determine whether Reslizumab effective treatment chronic sinusitis .</brief_summary>
	<brief_title>Effect Reslizumab Chronic Rhinosinusitis</brief_title>
	<detailed_description />
	<mesh_term>Sinusitis</mesh_term>
	<criteria>1 . Written inform consent 2 . Willingness ability comply requirement study 3 . Female male patient age 1875 time screen 4 . A diagnosis chronic rhinosinusitis accord clinical practice guideline ( update ) American academy otolaryngology head neck surgery 5 . Elevated blood eosinophils 6 . Significant finding compute tomography ( CT ) scan 1 . Unable sign inform consent form 2 . A woman pregnant nursing child 3 . Known hypersensitivity Reslizumab 4 . Active cigarette smoking year prior screen 5 . Known underlying immunodeficiency 6 . History alcohol drug abuse year prior screen Other criterion may apply . Please contact investigator information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>sinusitis , rhinitis , rhinosinusitis , chronic</keyword>
</DOC>